Older Males Had Best Plasma Potential

Google+ Pinterest LinkedIn Tumblr +

Medical researchers were examining the prospects of COVID-19 antibodies in donor blood plasma helping patients with the disease. They had reached the stage of investigating the personal factors influencing the size and overall quality of antibody stock. Then they used the criteria of age, sex, and disease severity in a test. The results indicated older males had best plasma potential in their sample.

A Small Sample of Older Males Had Best Plasma Potential

However, it’s essential to note these findings depend on a small sample of 126 adults who recovered from COVID-19 infection. We cannot therefore draw firm conclusions from this study. But knowing a small sample of older males had best plasma potential could become useful, if researchers replicate this in larger studies.

The research team used commercial tests to measure the level of antibodies in the blood samples. However, they trialed them for ability to neutralize SARS-CoV-2 cells in laboratory cultures.  And then they made their interesting discovery. This was strong antibody responses correlated with hospitalization, older age, and male gender.

Could These Indicators Be the Key to Effective Antibodies?

We already know older males have a relatively higher probability of becoming seriously ill after they contract COVID-19. The world needs more effective COVID-19 treatments, until we have vaccinated the people which may take several years.

Antibody therapies could be a way to infuse ill people with antibodies that could save lives. However, the scientists conducting the study cautioned against over-generalizing their findings without more extensive research.

They are none the less confident to make this recommendation. ‘Sex, age, and severity of disease should be used to guide the selection of donors for convalescent plasma transfer studies’. Professor Sabra Klein from Johns Hopkins Bloomberg School wrote up the study he published in Journal of Clinical Investigation on August 7, 2020.

Related

Donate Covid-19 Plasma To Give Others Hope

U.S. Clinical Trials of Monoclonal Antibodies

Preview Image: Diagram of ABO Blood Groups

Report in Journal of Clinical Investigation

Share.

About Author

Electricity has always intrigued me. I have been writing about batteries and energy storage for more than ten years, and have published over 4,000 articles on this website. During that time, I have researched developments across lead-acid, lithium-ion, sodium-ion, flow batteries, and emerging energy-storage technologies. My goal is to explain complex battery concepts in clear, practical language that anyone can understand. My writing career began unexpectedly after leaving the corporate world. What started as a search for a new direction gradually became a fascination with batteries, renewable energy, and the science that powers modern life. Writing may not have made me wealthy, but it has given me the opportunity to explore an industry that continues to evolve in remarkable ways.

Leave A Reply